Skip to Content

Pfizer confirms COVID pill’s results, potency versus omicron

KIFI

By MATTHEW PERRONE
AP Health Writer

WASHINGTON (AP) — Pfizer says that its experimental COVID-19 pill appears effective against the omicron variant. The company also confirmed Tuesday that the pill delivered on promising early results in reducing COVID-19 hospitalizations and deaths. The updates come as U.S. regulators are expected to soon decide on whether to authorize Pfizer’s pill and a competing drug from Merck. If authorized, the pills would be the first COVID-19 drugs that Americans could take at home to treat the virus. Pfizer is seeking U.S. authorization for high-risk adults but is also studying the drug in lower-risk adults. The company said the drug missed a key study goal in ongoing testing of those patients.

Article Topic Follows: AP National

Jump to comments ↓

Author Profile Photo

Associated Press

BE PART OF THE CONVERSATION

KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content